Home/Filings/4/0001415889-23-006687
4//SEC Filing

Johnson Marvin 4

Accession 0001415889-23-006687

CIK 0001267813other

Filed

Apr 18, 8:00 PM ET

Accepted

Apr 19, 4:03 PM ET

Size

7.5 KB

Accession

0001415889-23-006687

Insider Transaction Report

Form 4
Period: 2023-04-17
Transactions
  • Award

    Common Stock

    2023-04-17+7,2007,200 total
  • Award

    Stock Option (Right to Buy)

    2023-04-17+32,40032,400 total
    Exercise: $8.01Exp: 2033-04-17Common Stock (32,400 underlying)
Footnotes (2)
  • [F1]Represents the grant of restricted stock units (RSUs). The RSUs will vest in three equal annual installments, with the first installment vesting on April 17, 2024, the second installment vesting on April 17, 2025 and the third installment vesting on April 17, 2026, subject to the reporting person's continued service with Marinus Pharmaceuticals, Inc. (the Issuer). Each RSU represents the right to receive one share of common stock of the Issuer.
  • [F2]The option vests and becomes exercisable in 36 equal monthly installments beginning on May 17, 2023, subject to the reporting person's continued service with the Issuer.

Issuer

MARINUS PHARMACEUTICALS, INC.

CIK 0001267813

Entity typeother

Related Parties

1
  • filerCIK 0001852752

Filing Metadata

Form type
4
Filed
Apr 18, 8:00 PM ET
Accepted
Apr 19, 4:03 PM ET
Size
7.5 KB